A safety review of the use of Risedronate in the treatment of Paget's disease of bone.

被引：0
|
作者：
Singer, FR
Brown, JP
Siris, ES
Hoskings, DJ
Miller, PD
Ethgen, D
Axelrod, DW
机构：
[1] JOHN WAYNE CANC INST,SANTA MARIA IMBAR,ITALY
[2] CTR OSTEOPOROSE,QUEBEC CITY,PQ,CANADA
[3] COLUMBIA UNIV,DEPT MED,NEW YORK,NY
[4] CITY HOSP NOTTINGHAM,NOTTINGHAM,ENGLAND
[5] PROCTER & GAMBLE CO,PHARMACEUT,CINCINNATI,OH
来源：
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1489 / 1489
页数：1
相关论文
共 50 条
  • [31] Paget’s disease of bone: a review
    Matteo Colina
    Renato La Corte
    Francesco De Leonardis
    Francesco Trotta
    Rheumatology International, 2008, 28 : 1077 - 1077
  • [32] Paget's disease of bone: a review
    Colina, Matteo
    La Corte, Renato
    De Leonardis, Francesco
    Trotta, Francesco
    RHEUMATOLOGY INTERNATIONAL, 2008, 28 (11) : 1069 - +
  • [33] Paget’s disease of bone: a review
    Matteo Colina
    Renato La Corte
    Francesco De Leonardis
    Francesco Trotta
    Rheumatology International, 2008, 28 : 1069 - 1075
  • [34] Treatment of Paget's Disease of Bone
    Urteaga, Elizabeth M.
    US PHARMACIST, 2012, 37 (10) : 29 - 34
  • [35] Treatment of Paget's disease of bone
    Lojo Oliveira, Leticia
    Torrijos Eslava, Antonio
    REUMATOLOGIA CLINICA, 2012, 8 (04): : 220 - 224
  • [36] Risedronate sodium Actonel® Optinate® -: Treatment of osteoporosis -: Treatment of Paget's disease
    不详
    DRUGS OF THE FUTURE, 2000, 25 (07) : 769 - 771
  • [37] Treatment of Paget's disease of bone
    Arias M, Garcia
    Eslava A, Torrijos
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2011, 3 (01) : 35 - 40
  • [38] The use of urinary N-telopeptide of type I collagen (NTx) to monitor response to treatment of Paget's disease of bone.
    Bone, H
    Lyles, K
    Tucci, J
    Lombardi, A
    Barrett, J
    Flessland, K
    Mallinak, N
    Cain, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M757 - M757
  • [39] Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy
    Peris, P.
    Alvarez, L.
    Vidal, S.
    Martinez, M. A.
    Monegal, A.
    Guanabens, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 206 - 210
  • [40] Reduction of bone pain and alkaline phosphatase in patients with severe Paget's disease of bone following treatment with risedronate.
    Chines, A
    Bekker, P
    Clarke, P
    Hosking, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M760 - M760
12345